NDC 71335-1674 – Senna-plus

Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Tablet · Oral

Human Otc Drug

Product NDC71335-1674

Product details

Brand name
Senna-plus
Generic name
Sennosides and Docusate Sodium
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
OTC MONOGRAPH DRUG · 505G(a)(3)
Marketed since
May 1, 2019
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Senna Plus →

Package NDC codes (9)

Package NDCDescriptionSince
71335-1674-130 TABLET in 1 BOTTLE (71335-1674-1)Jul 1, 2021
71335-1674-2120 TABLET in 1 BOTTLE (71335-1674-2)Aug 18, 2020
71335-1674-360 TABLET in 1 BOTTLE (71335-1674-3)Sep 23, 2020
71335-1674-490 TABLET in 1 BOTTLE (71335-1674-4)Apr 4, 2024
71335-1674-5100 TABLET in 1 BOTTLE (71335-1674-5)Aug 7, 2020
71335-1674-628 TABLET in 1 BOTTLE (71335-1674-6)Aug 24, 2020
71335-1674-756 TABLET in 1 BOTTLE (71335-1674-7)Apr 4, 2024
71335-1674-814 TABLET in 1 BOTTLE (71335-1674-8)Apr 4, 2024
71335-1674-920 TABLET in 1 BOTTLE (71335-1674-9)Apr 4, 2024

Other Senna Plus products